Skip to content

Sjögren Syndrome - OASIZ

NO LONGER ACCEPTING APPLICATIONS
Published on:
September 18, 2024
Sign-up Expiration:
Updated:
Topics:
Locations:

To evaluate the effect of Dazodalibep on systemic manifestations of Sjögren's Syndrome (SS) in participants with moderate-to-severe systemic disease activity. To study the effect of Dazodalibep on patient reported outcomes (PROs) in participants with SS and the safety and tolerability of Dazodalibep in participants.

View Additional Information
View Clinical Trial Attachment
Sign Up NowExpired - View Other Trials
ENDED